AMICUS THERAPEUTICS, INC. Insider Trading for October 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMICUS THERAPEUTICS, INC. for October 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 19,013 | 67,116 | 20,508 | |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 52,722 | 186,109 | 39,521 | |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.76 | 19,013 | 280,544 | 328,001 | 347 K to 328 K (-5.48 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.76 | 19,013 | 280,544 | 347,014 | 328 K to 347 K (+5.80 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 52,722 | 777,650 | 328,001 | 380.7 K to 328 K (-13.85 %) |
Oct 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 52,722 | 777,650 | 380,723 | 328 K to 380.7 K (+16.07 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 40,000 | 100,800 | 6,224 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 14.25 | 40,000 | 570,132 | 95,121 | 135.1 K to 95.1 K (-29.60 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 14.25 | 40,000 | 570,132 | 135,121 | 95.1 K to 135.1 K (+42.05 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 2.29 | 5,000 | 11,450 | 140,000 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 14.25 | 5,000 | 71,268 | 64,184 | 69.2 K to 64.2 K (-7.23 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 14.25 | 5,000 | 71,268 | 69,184 | 64.2 K to 69.2 K (+7.79 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 6.10 | 14,582 | 88,950 | 35,418 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 35,612 | 104,699 | 9,388 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 14.25 | 50,194 | 715,360 | 473,207 | 523.4 K to 473.2 K (-9.59 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 14.25 | 50,194 | 715,360 | 523,401 | 473.2 K to 523.4 K (+10.61 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 7.15 | 5,000 | 35,750 | 5,000 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | M | 10.53 | 5,000 | 52,650 | 5,000 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Sell | S | 14.25 | 10,000 | 142,534 | 5,814 | 15.8 K to 5.8 K (-63.24 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Buy | M | 14.25 | 10,000 | 142,534 | 15,814 | 5.8 K to 15.8 K (+172.00 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 10.21 | 7,000 | 71,470 | 0 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 14.25 | 7,000 | 99,740 | 54,676 | 61.7 K to 54.7 K (-11.35 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 14.25 | 7,000 | 99,740 | 61,676 | 54.7 K to 61.7 K (+12.80 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 47,135 | 166,387 | 92,243 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 22,160 | 78,225 | 139,378 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 192,133 | 612,904 | 20,972 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 2.52 | 165,000 | 415,800 | 0 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 3,462 | 12,221 | 161,538 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.38 | 13,622 | 59,664 | 136,378 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 5,783 | 37,300 | 131,024 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 47,135 | 695,241 | 328,001 | 375.1 K to 328 K (-12.56 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 47,135 | 695,241 | 375,136 | 328 K to 375.1 K (+14.37 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.75 | 22,160 | 326,867 | 328,001 | 350.2 K to 328 K (-6.33 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.75 | 22,160 | 326,867 | 350,161 | 328 K to 350.2 K (+6.76 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.25 | 380,000 | 5,414,810 | 328,001 | 708 K to 328 K (-53.67 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 14.25 | 380,000 | 5,414,810 | 708,001 | 328 K to 708 K (+115.85 %) |